Evidence map›Paper›PMID 32779937›Full record

ArticleEnvironmental health perspectives2020

Arsenic Metabolism in Mice Carrying a

Beverly H Koller, John N Snouwaert, Christelle Douillet, Leigh A Jania, Hisham El-Masri, David J Thomas, Miroslav Stýblo

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Beverly H KollerDepartment of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
John N SnouwaertDepartment of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Christelle DouilletDepartment of Nutrition, UNC Gillings School of Public Health, Chapel Hill, North Carolina, USA.
Leigh A JaniaDepartment of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Hisham El-MasriChemical Characterization and Exposure Division, Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA.
David J ThomasChemical Characterization and Exposure Division, Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA.
Miroslav StýbloDepartment of Nutrition, UNC Gillings School of Public Health, Chapel Hill, North Carolina, USA.
University of North Carolina at Chapel Hill · USEnvironmental Protection Agency · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
The UNC Chapel Hill Superfund Research Program (UNC-SRP)P42ES031007 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Rebecca Fry · 2020 to 2026
$22.2M
Humanized mouse models for arsenic toxicologyR01ES032643 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOLLER, BEVERLY H, STYBLO, MIROSLAV · 2021 to 2025
$2.1M
Mechanisms of Arsenic-Induced Diabetes Mellitus - Administrative SupplementR01ES022697 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STYBLO, MIROSLAV · 2014 to 2017
$1.5M
A humanized mouse model for arsenic toxicologyR21ES029050 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOLLER, BEVERLY H, STYBLO, MIROSLAV · 2018 to 2019
$428k
NCI NIH HHS P30 CA016086NIDDK NIH HHS P30 DK056350NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES031007NIEHS NIH HHS R01 ES022697NIEHS NIH HHS R01 ES032643NIEHS NIH HHS R21 ES029050
6 · The paper itself

Abstract

backgroundChronic exposure to inorganic arsenic (iAs) is a significant public health problem. Methylation of iAs by arsenic methyltransferase (AS3MT) controls iAs detoxification and modifies risks of iAs-induced diseases. Mechanisms underlying these diseases have been extensively studied using animal models. However, substantive differences between humans and laboratory animals in efficiency of iAs methylation have hindered the translational potential of the laboratory studies.

objectivesThe goal of this study was to determine whether humanization of the

methodsWe generated a mouse strain in which the

results

conclusionsThese results suggest that

Indexed as

AnimalsArsenicArsenicalsHumansMethyltransferasesMiceArsenicArsenicalsMethyltransferases

Identifiers

PMID32779937
PMCPMC7418654
OpenAlexW3048849644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.